International consensus guideline update, convened by the Hairy Cell Leukemia Foundation, on diagnosing and managing hairy cell leukaemia (HCL) and HCL variant, replacing the 2017 guidelines and covering newer targeted therapies such as BRAF inhibitor-based treatment.
Guideline
Zent et al. Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant